Histotechnologists
29-2011.04Rank #628 of 923 scored · top 68% by substitution
Apply knowledge of health and disease causes to evaluate new laboratory techniques and procedures to examine tissue samples. Process and prepare histological slides from tissue sections for microscopic examination and diagnosis by pathologists. May solve technical or instrument problems or assist with research studies.
Sub-scores
0–100 · band = confidence interval from rater disagreement
Substitution22
Exposure19
Augmentation48
Substitution — the headline: capability discounted by cost, barriers and adoption.
Exposure — technical capability alone, regardless of whether anyone deploys it.
Augmentation — how much AI assists without replacing. High here + moderate substitution = a changing job, not a disappearing one.
Tasks on the substitution scale
16 rated tasks, binned by substitution score.
Position among all scored occupations
Distribution of 923 occupation scores; the marker is this occupation.
Tasks with substitution ≥ 70
0%
Run 1.0.0-draft.1 · computed 2026-08-05 · rater panel: claude-sonnet-5, claude-haiku-4-5-20251001 · intervals span rater disagreement.
Why this score
The five weighted dimensions of the composite, averaged across this occupation's tasks (importance-weighted, panel mean). Exact weights and formulas: /api/v1/methodology.
Task automatabilityw 35%20
panel mean rating 1.8/5 → substitution pressure 20/100
Technical feasibility todayw 20%17
panel mean rating 1.7/5 → substitution pressure 17/100
Cost vs. human wagew 15%18
panel mean rating 1.7/5 → substitution pressure 18/100
Adoption barriersw 20%inverted — strong barriers lower the score30
panel mean rating 3.8/5 (barrier strength) → substitution pressure 30/100
Sector adoption velocityw 10%24
panel mean rating 2.0/5 → substitution pressure 24/100
Task breakdown (16 tasks)
Substitution pressure per task, weighted by O*NET importance in the composite. Expand a task for the full rater audit trail — every rating, every model, every rationale.
Compile materials for distribution to pathologists, such as surgical working drafts, requisitions, and slides.
59CI 30–87 · exposure 58 · augmentation 63 · importance 4.6/5 · click for rater detail
Compile materials for distribution to pathologists, such as surgical working drafts, requisitions, and slides.
59| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 4/5 | Clinical laboratories and pathology practices are digitizing rapidly, with widespread adoption of laboratory information systems (LIS) and automated specimen tracking. Material distribution workflows are being integrated into these platforms in medium to large facilities at a steady pace, though smaller labs lag. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Clinical laboratory settings are slower adopters of AI for physical workflow tasks compared to purely digital knowledge work sectors, with most AI focus in this field on image analysis rather than logistics. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI systems can assist histotechnologists by automatically flagging missing or mismatched materials, suggesting optimal distribution routes, and pre-populating requisition data, thereby freeing technologists to focus on quality verification and exception handling rather than manual compilation and routing. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI can assist with organizing requisition data, generating draft paperwork, or flagging missing items, providing moderate support to the administrative portion of this task. |
| Task automatability | claude-haiku-4-5-20251001 | 5/5 | The task of compiling materials (surgical drafts, requisitions, slides) for distribution is fundamentally a document assembly and routing operation. Current AI systems can extract data from multiple sources, organize it into structured formats, match requisitions to slides, generate cover sheets, and trigger automated delivery—easily achieving >50% time savings at equal quality without meaningful human involvement. |
| Task automatability | claude-sonnet-5 | 2/5 | This involves physical handling of slides and coordination of lab materials alongside document compilation, so only the document-related subset (requisitions, drafts) could be AI-assisted, not the physical slide handling.the majority remains manual.5 |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | While some oversight and verification may be expected (checking that correct slides match correct requisitions), there are no legal requirements mandating a licensed human perform material compilation and distribution itself. Regulatory and liability barriers are minimal; quality assurance can be integrated into the automation workflow. |
| Adoption barriers | claude-sonnet-5 | 3/5 | Handling of clinical specimens and chain-of-custody documentation in pathology labs typically involves regulatory and accreditation requirements (e.g., CAP, CLIA) that require human oversight and accountability. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 5/5 | The per-task cost of AI-driven document compilation and routing (image scanning, metadata extraction, automated distribution via lab information systems) is orders of magnitude cheaper than the loaded wage of a histotechnologist performing manual assembly and hand-delivery of materials. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | Physical material handling still requires human labor for slide/specimen management, so AI cannot substantially reduce cost for this task as a whole, though some paperwork automation is cheap. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 4/5 | Document management and workflow automation products are mature and deployed in clinical laboratories today. Automated specimen tracking, slide labeling, and requisition routing systems operate at scale in pathology workflows. Reliability is high for routine cases, though complex edge cases (specimen mismatches, unusual routing) may still require human oversight. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | No deployed product handles the physical assembly and distribution of pathology slides and paperwork; document management systems exist but aren't integrated for this specific lab workflow at scale. |
Compile and maintain records of preventive maintenance and instrument performance checks according to schedule and regulations.
40CI 30–50 · exposure 42 · augmentation 63 · importance 4.5/5 · click for rater detail
Compile and maintain records of preventive maintenance and instrument performance checks according to schedule and regulations.
40| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Histopathology labs adopt specialized LIS and maintenance software, but adoption of AI-driven autonomous record management remains limited; most organizations rely on traditional logging and human verification practices. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | Clinical laboratories have moderately adopted LIMS and automated documentation systems, but many smaller labs still rely on manual or semi-manual logging, reflecting middling sector-wide digitization. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can assist by auto-generating reminders, flagging overdue checks, and suggesting record entries based on instrument logs, meaningfully reducing clerical burden while the histotechnologist retains verification and compliance responsibility. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI-enabled LIMS and automated reminder/scheduling systems substantially reduce the manual burden of tracking maintenance schedules and generating compliance reports, meaningfully boosting technologist efficiency. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | Record compilation and maintenance scheduling can be partially automated (data entry, log reminders), but the task requires domain knowledge about regulatory compliance, interpretation of performance check results, and decision-making about maintenance timing that exceed current AI capability without heavy supervision. |
| Task automatability | claude-sonnet-5 | 3/5 | Compiling and maintaining structured maintenance logs is largely a data entry and record-keeping task that AI/software can significantly automate, though the actual instrument checks require human physical action and observation.: |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Regulatory frameworks (CAP, CLIA standards) typically require a qualified human to verify and sign off on maintenance records and compliance documentation, creating a hard barrier to full automation. |
| Adoption barriers | claude-sonnet-5 | 3/5 | Regulatory requirements (CLIA, CAP, ISO 15189) mandate documented preventive maintenance and quality records, often requiring qualified personnel sign-off, creating moderate compliance friction against full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | Current AI solutions for compliance record management require significant customization and oversight infrastructure, making total cost per task comparable to or exceeding a histotechnologist's time to maintain records manually. |
| Cost vs. human wage | claude-sonnet-5 | 3/5 | Digital record-keeping software is cheap relative to technologist time spent on documentation, but implementation, validation, and compliance oversight keep costs from being an order of magnitude lower. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 3/5 | Laboratory information systems and maintenance scheduling software exist and are deployed, but most require human input for interpretation and approval; no end-to-end autonomous performance exists at scale without ongoing oversight. |
| Technical feasibility today | claude-sonnet-5 | 3/5 | Laboratory information management systems (LIMS) and CMMS software already automate scheduling and record-keeping reliably, but integration with actual manual maintenance checks and regulatory sign-off still requires human input and verification. |
Operate computerized laboratory equipment to dehydrate, decalcify, or microincinerate tissue samples.
25CI 25–25 · exposure 25 · augmentation 50 · importance 4.4/5 · click for rater detail
Operate computerized laboratory equipment to dehydrate, decalcify, or microincinerate tissue samples.
25| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Adoption of robotic specimen processors in clinical labs is slow and concentrated in large hospital systems; many smaller labs lack capital and infrastructure. Most histopathology labs still rely on manual or semi-automated workflows with substantial human intervention. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Clinical/anatomic pathology labs are slow to adopt new automation due to regulatory validation requirements, accreditation, and capital costs, resulting in incremental rather than fast adoption. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | Current laboratory automation tools assist technologists by reducing manual handling time and standardizing cycle parameters, improving consistency and reducing physical strain. However, the cognitive load of monitoring and troubleshooting remains high, limiting productivity gains. |
| Augmentation potential | claude-sonnet-5 | 3/5 | Computerized equipment already assists technologists by standardizing dehydration/decalcification cycles and reducing manual timing errors, improving consistency and throughput while the human remains responsible for setup and quality checks. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While the equipment operation itself is partially automatable (loading samples, running preset cycles), the task requires monitoring for anomalies, interpreting tissue condition, and adjusting parameters mid-process—judgments that demand human expertise today. Current AI lacks the visual and contextual reasoning to handle sample variance reliably. |
| Task automatability | claude-sonnet-5 | 2/5 | This involves physical manipulation of tissue samples and operation of specialized lab hardware, which current AI (software/LLM-based) cannot perform end-to-end; automation here is more about existing lab automation equipment than AI per se.' |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Clinical laboratory work is regulated by CLIA and CAP, which impose quality assurance and personnel certification requirements; specimen handling must be traceable and auditable. A licensed histotechnologist must oversee and validate critical processing steps, creating regulatory barriers to full automation. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Histotechnology is a licensed/certified role in many jurisdictions with strict lab accreditation and quality control standards, requiring human sign-off on specimen processing for diagnostic validity. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | Automated equipment is capital-intensive and requires integration with lab infrastructure, plus ongoing technologist oversight remains necessary. The all-in cost of semi-automated systems is comparable to or higher than a histotechnologist's labor for small to mid-sized labs. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | Specialized processing equipment is costly to acquire, calibrate, and maintain, and still requires skilled technologist oversight, so cost savings versus human labor are modest rather than order-of-magnitude. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | Laboratory automation exists for specimen processing, but deployed systems require human oversight, sample preparation, and intervention when unexpected conditions arise. No production system reliably performs end-to-end processing of diverse tissue types without technologist involvement. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | Automated histology processors exist and are used in labs, but they are pre-programmed instruments, not AI systems that adaptively decide processing parameters, and human technologists still load, monitor, and troubleshoot them. |
Prepare substances, such as reagents and dilution, and stains for histological specimens according to protocols.
25CI 25–25 · exposure 25 · augmentation 38 · importance 4.4/5 · click for rater detail
Prepare substances, such as reagents and dilution, and stains for histological specimens according to protocols.
25| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | While high-volume clinical and research labs have adopted commercial autostainers for routine staining, broader automation of reagent preparation remains limited. Most histology departments, especially smaller ones, continue manual or semi-manual preparation due to cost and regulatory friction. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Clinical and anatomic pathology labs are historically slow adopters of full automation for wet-lab chemical processes, prioritizing reliability and regulatory compliance over novel AI tools. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | Digital protocols, barcode tracking, and automated dilution calculators provide useful assistive support for technologists preparing reagents. However, the hands-on nature of the work and need for human judgment on protocol compliance limit the transformative potential of current augmentation tools. |
| Augmentation potential | claude-sonnet-5 | 2/5 | AI can assist with protocol documentation, inventory tracking, or dilution calculations, but offers limited transformative support for the core physical mixing and preparation task. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While liquid handling and reagent mixing can be partially automated with robotic systems, the task requires protocol adherence, quality verification, and real-time adjustment based on specimen characteristics. Current general-purpose AI lacks the embodied capability to reliably perform multi-step chemical preparation end-to-end without human supervision. |
| Task automatability | claude-sonnet-5 | 2/5 | This involves precise manual liquid handling, chemical mixing, and physical preparation of reagents and stains which AI software cannot perform; only robotic lab automation (not general AI) could partially help, and that requires physical infrastructure beyond current 'AI' scope.a rating of 2 reflects marginal digital assistance (calculation, protocol lookup) but no end-to-end automation. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Histology labs operate under strict CLIA and CAP regulations requiring documented human oversight of reagent preparation and quality control. Protocol changes, verification of reagent integrity, and liability for stain-related errors create significant regulatory and legal barriers to full automation. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Histology work is regulated under clinical lab standards (e.g., CLIA, CAP), requiring certified personnel to prepare and verify reagents used in diagnostic specimens, creating strong compliance barriers to full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | Robotic liquid handlers and automated staining systems have high capital costs ($100k+) with integration and maintenance overhead. For small-to-medium labs, the total cost per task remains comparable to or exceeds the cost of a technologist's hourly labor on these preparation tasks. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | Automated staining/reagent equipment requires significant capital investment, calibration, and maintenance, often costing more than technician time for many labs, especially smaller ones. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | Specialized laboratory automation exists for high-volume standardized staining (e.g., commercial slide stainers), but general reagent preparation and dilution workflows lack mature AI-driven deployment in typical histology labs. Most systems remain semi-automated, requiring technologist oversight and manual intervention. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | Lab automation systems (liquid handlers, automated stainers) exist but are specialized hardware, not general AI products, and adoption for full reagent/stain prep according to variable protocols remains limited and lab-specific. |
Examine slides under microscopes to ensure tissue preparation meets laboratory requirements.
25CI 25–25 · exposure 25 · augmentation 50 · importance 4.3/5 · click for rater detail
Examine slides under microscopes to ensure tissue preparation meets laboratory requirements.
25| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Healthcare and clinical laboratory automation lags information/finance sectors; adoption of AI for slide QC remains in pilot phases at specialized centers, not widespread production deployment across typical histology labs. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Clinical histology labs are slow adopters of full automation due to regulatory validation requirements, though digital pathology adoption is growing gradually. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI-assisted image analysis and flagging of potential defects can help a histotechnologist prioritize review work and catch some artifacts more efficiently, but the task remains fundamentally human-supervised quality gatekeeping. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI image analysis tools can help flag artifacts or inconsistent staining, assisting technologists in prioritizing slides for closer review. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While AI image analysis can classify some histological slides, end-to-end automation requiring judgment about tissue adequacy, artifact detection, and variable staining quality falls short of the 50% time-saving threshold with current systems. Histotechnologists perform nuanced visual inspection that remains largely manual today. |
| Task automatability | claude-sonnet-5 | 2/5 | Slide quality assessment requires nuanced visual judgment of staining, fixation, and sectioning artifacts that current AI vision systems can partially flag but not reliably certify end-to-end without human confirmation.dvancement. }fictionous |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Clinical laboratories operate under CLIA and accreditation requirements that typically mandate human review of tissue adequacy and slide quality; regulatory expectations and liability asymmetry strongly favor human sign-off on preparation sufficiency before downstream processing. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Clinical laboratory regulations (CLIA/CAP) typically require qualified personnel to verify specimen adequacy before diagnostic use, creating strong compliance-driven barriers. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | High-quality microscopy image capture, AI model inference, and required human oversight for quality assurance remain costly relative to a histotechnologist's loaded wage, especially given the need for reliable error detection in a safety-critical setting. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | Whole-slide scanners and AI QC software require significant capital and integration costs that are not yet clearly cheaper than a technologist's routine visual check. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | Research-grade AI and some prototype tools can detect gross defects in slide images, but no mature, deployed product reliably performs full tissue-preparation-quality assessment in production laboratory workflows at scale. Clinical-grade validation and integration remain limited. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | digital pathology tools exist for image analysis but few products are validated specifically for pre-analytic tissue-preparation quality control in routine lab workflows. |
Identify tissue structures or cell components to be used in the diagnosis, prevention, or treatment of diseases.
25CI 25–25 · exposure 25 · augmentation 75 · importance 3.9/5 · click for rater detail
Identify tissue structures or cell components to be used in the diagnosis, prevention, or treatment of diseases.
25| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Adoption in histopathology remains slow and pilot-heavy; while academic medical centers and large labs experiment with AI-assisted image analysis, most routine histology work in smaller and mid-size labs is still manual. Digital pathology infrastructure itself is still being rolled out. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare/clinical lab settings are historically slow adopters of AI due to regulatory hurdles, validation requirements, and conservative practice norms, despite growing digital pathology pilots. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI significantly augments histotechnologists by automating preliminary screening, flagging suspicious areas, and standardizing image acquisition and feature detection, enabling technologists to focus on complex cases and quality assurance. This assistive use is already demonstrable in production lab settings. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI-assisted image analysis tools can highlight regions of interest, quantify staining, and support histotechnologists' analysis, meaningfully boosting productivity while humans remain responsible for final identification. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | Histological image analysis can be partially automated with AI-assisted detection of certain tissue features, but the nuanced interpretation of tissue morphology and integration into diagnostic pathways requires human expertise. Current systems cannot reliably handle the full diagnostic decision-making end-to-end with the quality consistency required for clinical use. |
| Task automatability | claude-sonnet-5 | 2/5 | AI image analysis can flag or highlight tissue features, but final identification for diagnostic use still requires human histotechnologist/pathologist judgment and quality control, so end-to-end automation with equal quality is not yet achieved. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Regulatory barriers are substantial: pathology and diagnostics fall under clinical laboratory standards (CLIA, CAP) and diagnostic device regulations (FDA), requiring validation, approval, and often licensed pathologist sign-off. Liability asymmetry is high—misdiagnosis directly affects patient outcomes. Human oversight is legally embedded. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Diagnostic tissue identification is tightly regulated (CLIA, CAP) and typically requires certified personnel and pathologist sign-off, creating strong licensing and liability barriers to full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | AI-assisted histology platforms carry significant infrastructure and licensing costs; when integrated with human oversight (required for safety), the total cost per diagnostic case remains comparable to or higher than traditional histotechnologist labor in most deployment scenarios. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | AI image analysis systems require expensive scanning hardware, software licensing, and validation, making per-sample costs not clearly cheaper than human histotechnologist labor at current adoption levels. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | While AI systems for histopathology image analysis exist (e.g., WSI analyzers, nuclear detection), they operate primarily as assistive tools with material error rates and are deployed in limited institutional settings, not yet at scale as autonomous diagnostic agents. Most rely on human review and validation. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | Digital pathology AI tools exist for specific tasks (e.g., cancer detection algorithms) but are narrow, require validated slide scanners, and are not broadly deployed for general tissue/cell structure identification across labs. |
Prepare or use prepared tissue specimens for teaching, research or diagnostic purposes.
21CI 16–25 · exposure 20 · augmentation 63 · importance 4.1/5 · click for rater detail
Prepare or use prepared tissue specimens for teaching, research or diagnostic purposes.
21| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Adoption of automated staining and imaging has grown in large academic and clinical labs, but remains modest in smaller facilities; most histology departments still rely heavily on manual preparation and human oversight. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Clinical laboratory and histology work is a physically intensive, moderately digitized sector where AI adoption for actual specimen handling remains minimal despite growth in digital pathology imaging tools. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI-powered image analysis, quality control systems, and digital pathology workflows substantially augment histotechnologists' productivity by automating screening, flagging anomalies, and enabling remote review while the technologist retains control over specimen preparation decisions. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI-assisted image analysis and quality-control tools can help histotechnologists review stained slides or flag anomalies, but core specimen preparation itself sees little AI augmentation. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While AI can assist with image analysis and specimen classification, the core task of physically preparing tissue specimens—sectioning, staining, mounting—requires manual dexterity and real-time adjustments that current automation cannot reliably perform end-to-end at scale or with sufficient quality consistency. |
| Task automatability | claude-sonnet-5 | 2/5 | This task requires substantial physical manipulation (embedding, sectioning, mounting tissue) that current AI cannot perform; only narrow sub-steps like image analysis or documentation could be automated, far below the 50% end-to-end threshold. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Quality assurance requirements, regulatory oversight (CAP, CLIA accreditation), and liability concerns for diagnostic specimens create strong organizational and compliance barriers; human validation and sign-off are typically mandatory in clinical settings. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Histotechnology involves regulated lab procedures (CLIA, accreditation standards) often requiring certified personnel, and diagnostic use imposes liability and quality-control requirements limiting automation of physical prep. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | High-quality automated tissue processors and slide imaging systems are capital-intensive and require ongoing maintenance and oversight, making the per-specimen cost comparable to or exceeding skilled technologist labor for many workflows. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | AI cannot substitute for the physical lab work involved, so there is no viable AI cost basis to compare against the human wage for this task. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | Automated slide scanners and image analysis tools exist in production, but fully automated tissue preparation systems remain limited and largely research-stage; most deployed solutions handle only narrow subtasks like imaging, not complete specimen preparation. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed AI product performs physical tissue preparation; digital pathology AI tools exist only for downstream image analysis, not the specimen preparation task itself. |
Perform procedures associated with histochemistry to prepare specimens for immunofluorescence or microscopy.
21CI 16–25 · exposure 20 · augmentation 38 · importance 4.0/5 · click for rater detail
Perform procedures associated with histochemistry to prepare specimens for immunofluorescence or microscopy.
21| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Histology labs have adopted incremental automation (stainers, some liquid handlers) but remain labor-intensive and slow to adopt end-to-end robotic workflows due to variability in specimen types, regulatory burden, and capital constraints in many facilities. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Clinical laboratory settings adopt automation slowly due to regulatory validation requirements, though some instrument-based automation (autostainers) has been adopted for narrow steps over years, not rapid AI-driven change. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | Digital image analysis and AI-assisted microscopy interpretation tools provide useful augmentation for quality control and archiving, but the hands-on specimen preparation itself benefits only modestly from current AI assistance. |
| Augmentation potential | claude-sonnet-5 | 2/5 | AI can assist with image analysis, protocol optimization, or quality control flagging post-preparation, but offers limited direct assistance to the physical specimen preparation task itself. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While some substeps (reagent preparation, incubation timing) could be partially automated, the task requires precise manual specimen handling, positioning on slides, and visual judgment during staining procedures that current robotics cannot reliably replicate end-to-end at production quality. |
| Task automatability | claude-sonnet-5 | 2/5 | This involves hands-on physical lab work (tissue processing, staining, fixation) requiring fine motor manipulation of physical specimens, which current AI cannot perform; only ancillary data/documentation aspects could be automated. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Clinical specimen handling is regulated under CLIA and CAP standards, requiring quality assurance sign-off by qualified personnel; specimen integrity and chain-of-custody obligations create strong legal and liability requirements that protect human technician involvement. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Histotechnology requires certification/licensure in many jurisdictions, strict quality control and regulatory compliance (CLIA, CAP), and clinical liability for diagnostic specimen integrity, creating strong barriers to full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | Existing laboratory automation equipment is capital-intensive and requires skilled technician oversight, making the all-in cost comparable to or higher than trained histotechnologists for typical specimen volumes. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | Physical lab automation equipment (stainers, robotic processors) is capital-intensive and still requires skilled technologist oversight, making all-in cost comparable or higher than human labor for many labs. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | Limited automation exists for specific substeps (liquid handlers for reagent dispensing), but no integrated deployed system performs the full immunofluorescence or microscopy specimen preparation reliably without human oversight and intervention. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed AI product performs physical histochemistry staining or specimen preparation; lab automation for this exists but is robotics/hardware-based, not general AI, and remains narrow and research/early-adoption stage. |
Teach students or other staff.
19CI 7–30 · exposure 13 · augmentation 63 · importance 3.7/5 · click for rater detail
Teach students or other staff.
19| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Histotechnology education remains predominantly instructor-led in clinical and laboratory settings. While some institutions use supplementary online content, adoption of AI-driven teaching as a replacement is minimal and limited to content generation rather than active instruction. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare/lab settings, including histotechnology training, adopt AI slowly due to specialized technical skills, safety protocols, and limited digitization of hands-on instruction. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can assist instructors by generating practice questions, summarizing complex procedures, or creating visual aids for histological concepts. However, the augmentation is partial—instructor oversight and active engagement remain essential for feedback and adaptive teaching. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI can meaningfully assist by creating lesson plans, quizzes, explanatory content, and answering procedural questions, enhancing an instructor's efficiency while they remain central to hands-on teaching. |
| Task automatability | claude-haiku-4-5-20251001 | 1/5 | Teaching requires dynamic feedback, responsive adaptation to learner needs, and judgment about how to explain concepts effectively—all areas where current AI lacks the interactivity and contextual awareness needed for end-to-end performance at equal quality. While AI can generate educational materials, it cannot replicate the mentoring, real-time problem-solving, and relationship-building central to teaching histotechnologists. |
| Task automatability | claude-sonnet-5 | 2/5 | Teaching involves live demonstration, hands-on lab supervision, and adaptive feedback that current AI cannot fully replicate end-to-end, though it can help prepare materials.' |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Teaching in professional and continuing education settings typically requires accreditation, licensed instructors, and direct credential authority. Regulatory bodies governing histotechnology training programs mandate qualified human instructors, creating hard barriers to AI substitution. |
| Adoption barriers | claude-sonnet-5 | 3/5 | No strict licensing requirement to teach, but organizational expectations for supervised, hands-on lab training and quality control create moderate friction against full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 1/5 | Full teaching automation is not achieved, so direct cost comparison is not meaningful; moreover, any partial AI tools for content creation or tutoring still require substantial instructional expertise and oversight, keeping total cost above that of traditional teaching labor. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | Creating supplementary training materials with AI is cheap, but the core in-person teaching/supervision still requires a paid expert, keeping overall cost comparable to human-led training. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 1/5 | No production system today autonomously teaches students or staff with comparable outcomes to a qualified instructor. Educational AI tools exist for content delivery, but they do not meet the bar of reliable, deployed performance for the full teaching task in real histotechnology training environments. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | AI products exist for generating training content and quizzes but no deployed system reliably conducts hands-on histotechnology instruction or staff training in production. |
Stain tissue specimens with dyes or other chemicals to make cell details visible under microscopes.
16CI 7–25 · exposure 13 · augmentation 38 · importance 4.7/5 · click for rater detail
Stain tissue specimens with dyes or other chemicals to make cell details visible under microscopes.
16| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Adoption of automated staining is slow in practice; most smaller and mid-sized clinical and research labs still rely on manual histotechnologists, and even large labs often maintain manual backup due to equipment limitations and staffing constraints. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Clinical histology labs are moderately digitized but physical sample processing remains slow to automate with AI; existing automation is via dedicated staining machines, not AI systems, and adoption of AI specifically for this step is minimal. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI-assisted microscopy image analysis and protocol recommendation systems can help histotechnologists optimize staining decisions and quality control, improving productivity and consistency, but human judgment on specimen preparation and troubleshooting remains essential. |
| Augmentation potential | claude-sonnet-5 | 2/5 | AI can help optimize staining protocols, flag quality issues, or analyze stained images afterward, but it offers little direct assistance to the physical staining task itself. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While tissue staining protocols are well-documented and repetitive, the task requires precise handling of biological specimens, timing-dependent chemical reactions, and quality assessment that current robots cannot reliably perform end-to-end without human oversight. AI vision systems could monitor some aspects, but manual dexterity and adaptive troubleshooting remain bottlenecks. |
| Task automatability | claude-sonnet-5 | 1/5 | This is a hands-on wet-lab procedure requiring physical manipulation of tissue samples, chemical staining processes, and equipment operation that current AI cannot physically execute. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Histotechnology requires licensure (HT or HTL credentials) in most U.S. states, and final quality sign-off on stained specimens typically falls to a licensed professional; clinical labs also face accreditation requirements (CLIA) that mandate human responsibility for specimen processing integrity. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Histology staining is typically performed under lab accreditation and quality-control standards (e.g., CLIA, CAP) requiring trained/certified personnel, creating regulatory and liability barriers to full automation via AI. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | Automated staining equipment is capital-intensive ($50k–$200k+) with ongoing reagent and maintenance costs; for typical lab volumes and the specialized oversight required, total cost per specimen is comparable to or exceeds skilled labor, especially when factoring in downtime and rechecks. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | There is no AI substitute for the physical act of staining; automated stainers exist but are lab hardware, not AI, and require human oversight and loaded costs comparable to or exceeding a technologist's wage for the actual task. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | Automated staining systems exist in research and some clinical labs, but they handle only standardized specimens and protocols; they cannot accommodate the variability in tissue types, sizes, and damage states that histotechnologists encounter, nor can they reliably assess stain quality without human review. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed AI product performs the physical staining of tissue specimens; this remains a manual/robotic-instrument-assisted lab process, not an AI task per se. |
Perform tests by following physician instructions.
16CI 7–25 · exposure 13 · augmentation 38 · importance 4.5/5 · click for rater detail
Perform tests by following physician instructions.
16| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Histotechnology adoption of automation remains limited to specific high-volume tasks (slide scanning, image analysis). Most histology labs continue to rely on trained technologists for core procedures, reflecting slow sector-wide adoption of end-to-end automation in clinical laboratory settings. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Clinical laboratory settings adopt AI cautiously and slowly for physical testing tasks, with digitization mainly in image analysis rather than physical specimen handling and test execution. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can meaningfully assist histotechnologists through automated slide scanning, image analysis for pathology support, and documentation assistance, improving workflow efficiency without replacing the technologist's core analytical and hands-on responsibilities. |
| Augmentation potential | claude-sonnet-5 | 2/5 | AI can assist with documentation, protocol lookup, or interpreting digitized images from stains, but it offers limited direct assistance to the physical execution of tests per physician instructions. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While AI could assist in interpreting some aspects of physician instructions, histotechnology requires precise manual laboratory procedures (tissue processing, staining, specimen handling) that demand physical manipulation and real-time quality control. Current AI cannot perform the hands-on technical execution that constitutes the majority of this task. |
| Task automatability | claude-sonnet-5 | 1/5 | This involves physical laboratory sample preparation and testing that requires manual dexterity, precise physical technique, and interpretation of physician instructions applied to unique specimens; current AI cannot perform the physical test execution.4 |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Clinical laboratory work is heavily regulated by CLIA and similar frameworks; test performance and reporting often require a licensed professional's sign-off. Additionally, quality control, specimen integrity, and liability concerns create substantial legal and regulatory barriers to full automation. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Histotechnology is a regulated, certified profession with clinical accountability, quality control standards (CLIA, CAP), and liability concerns tied to diagnostic accuracy, creating strong barriers to full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | The cost of lab automation equipment plus AI integration and oversight would likely exceed or match the salary of a trained histotechnologist, especially when accounting for the specialized nature of this work and lower test volumes in many settings. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | There is no viable AI substitute performing the physical task, so AI cost is not comparable; robotics/automation for full test execution would be far more expensive than current skilled labor if it existed at all. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | No deployed product reliably performs the end-to-end execution of histotechnology tests. AI systems can assist with documentation and some image analysis, but the physical lab work, specimen preparation, and quality assurance steps remain human-dependent in production settings. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed AI product performs physical histology test procedures autonomously; this remains a hands-on laboratory task performed by trained technologists using specialized equipment. |
Perform electron microscopy or mass spectrometry to analyze specimens.
16CI 7–25 · exposure 13 · augmentation 50 · importance 3.5/5 · click for rater detail
Perform electron microscopy or mass spectrometry to analyze specimens.
16| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Adoption of AI-assisted analysis tools in histology and pathology is emerging but remains slow. Most labs continue traditional workflows; AI integration into microscopy pipelines is in pilot phases rather than widespread production deployment across the sector. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Clinical laboratory and pathology settings adopt AI slowly for physical specimen handling tasks, though image analysis software is gradually integrated for interpretation support. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can meaningfully assist by automating image segmentation, feature extraction, and initial pattern recognition from microscopy or spectrometry data, helping technologists interpret results faster. However, the human expert remains essential for validation, quality assurance, and complex interpretations, making augmentation moderate but valuable. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI-based image analysis and pattern recognition can assist in interpreting electron micrographs or mass spec data, aiding the human analyst without replacing the physical operation of instruments. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | Electron microscopy and mass spectrometry involve complex instrument operation, sample preparation, and interpretation of results. While AI can assist with image analysis and data interpretation, the hands-on operation of sensitive equipment, troubleshooting, and critical pre-analytical decisions remain largely manual, preventing 50% time savings end-to-end. |
| Task automatability | claude-sonnet-5 | 1/5 | Operating electron microscopes or mass spectrometers on physical tissue specimens requires manual sample handling, instrument calibration, and physical manipulation that current AI cannot perform end-to-end.' |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Significant barriers exist: equipment operation requires specialized training and certification; many institutions have strict protocols for equipment use; results often require expert human interpretation and sign-off for diagnostic or research purposes; liability for instrument-generated data introduces organizational friction. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Histotechnology in clinical settings is often regulated (CLIA, credentialing) and requires trained/certified personnel to operate specialized equipment and validate diagnostic-grade results. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | Electron microscopy and mass spectrometry require expensive capital equipment, maintenance, and skilled operators. AI tools for data analysis have modest inference costs, but cannot replace the equipment or specialized personnel, making the overall cost comparison unfavorable for full automation. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | The physical instrumentation, specimen prep, and operation still require skilled human technologists, so AI cannot substitute at lower cost since it cannot perform the physical task at all. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | AI products exist for spectral analysis and microscopy image post-processing, but no deployed system can autonomously operate electron microscopes or mass spectrometry equipment reliably in production. Current tools handle data interpretation, not the full procedural workflow including calibration and sample handling. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed product autonomously performs electron microscopy or mass spectrometry specimen analysis in clinical/lab settings; these remain human-operated with software-assisted analysis only. |
Resolve problems with laboratory equipment and instruments, such as microscopes, mass spectrometers, microtomes, immunostainers, tissue processors, embedding centers, and water baths.
14CI 7–21 · exposure 8 · augmentation 50 · importance 4.3/5 · click for rater detail
Resolve problems with laboratory equipment and instruments, such as microscopes, mass spectrometers, microtomes, immunostainers, tissue processors, embedding centers, and water baths.
14| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Laboratories have adopted digital logging and remote monitoring tools, but actual problem resolution remains human-dependent. Adoption of AI-driven equipment diagnostics is still nascent and limited to vendor-specific implementations rather than broad sectoral change. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Clinical and research laboratory settings adopt AI slowly for physical maintenance tasks, with digitization focused on data analysis rather than equipment repair workflows. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI could usefully assist technicians by analyzing equipment logs, suggesting common causes from manufacturer documentation, or prioritizing troubleshooting steps, but the core diagnostic and repair work requires human expertise and physical manipulation. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI can assist by providing diagnostic guidance, error code lookups, or predictive maintenance alerts, helping technologists troubleshoot faster even though it cannot perform the physical fix itself. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | Troubleshooting complex laboratory equipment requires physical diagnosis, hands-on testing, and real-time decision-making based on equipment-specific error codes and behavioral patterns. While AI could assist with diagnostic flowcharts or documentation review, resolving the actual problem typically requires human technician intervention with specialized training and physical access to the equipment. |
| Task automatability | claude-sonnet-5 | 1/5 | Troubleshooting physical lab equipment requires hands-on diagnosis, manipulation, and repair that current AI systems cannot perform end-to-end; this is a physical, sensor-and-hands task outside AI's capability. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Liability, warranty compliance, and regulatory requirements (especially in clinical laboratory settings under CLIA) often mandate that equipment troubleshooting be performed or signed off by qualified personnel. Equipment manufacturers retain tight control over service through certification programs and authorized technicians. |
| Adoption barriers | claude-sonnet-5 | 3/5 | No strict licensing barrier prevents non-human problem-solving, but equipment complexity, safety, and need for physical intervention create practical organizational friction against any automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 1/5 | The specialized knowledge required, combined with the cost of equipment downtime and the need for trained technicians on-site, means that AI solutions do not yet offer cost parity with or advantage over human technicians for this safety-critical task. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | There is no AI system that substitutes for the physical technician labor and hands-on repair needed, so cost comparison favors the human by default since AI cannot perform the task at all. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 1/5 | No deployed AI systems reliably diagnose and resolve problems with specialized laboratory instruments like mass spectrometers or automated immunostainers in production environments. Equipment vendors provide their own support and troubleshooting systems, but these are not AI-driven replacements for human technicians. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed product autonomously diagnoses and resolves physical malfunctions in histology equipment; at most, AI could offer diagnostic chatbots referencing manuals, which is not the actual task. |
Supervise histology laboratory activities.
14CI 7–20 · exposure 8 · augmentation 50 · importance 3.8/5 · click for rater detail
Supervise histology laboratory activities.
14| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Clinical laboratory automation is advancing but supervision tasks remain human-centric; pilot AI monitoring tools exist but production deployment of AI-driven supervision is rare, with adoption concentrated in large institutional labs. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Clinical laboratory settings are cautious adopters of AI for operational management, with slow, compliance-heavy integration despite some diagnostic AI tool adoption. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can assist supervisors through automated monitoring dashboards, quality-control flagging, and documentation support, raising productivity on routine oversight tasks while the human supervisor retains decision authority and staff management. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI can assist with scheduling, quality-control data analysis, and workflow tracking, aiding a supervisor's oversight tasks without replacing the supervisory judgment and accountability role. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | Histology lab supervision requires real-time oversight of complex procedures, equipment troubleshooting, staff coordination, and quality assurance decisions. While AI could assist with monitoring some metrics or documentation, human judgment on procedural deviations and personnel management cannot be meaningfully automated to a 50% time-savings threshold. |
| Task automatability | claude-sonnet-5 | 1/5 | Supervising a laboratory involves managing people, quality control, judgment calls, and accountability that current AI cannot perform end-to-end; no meaningful time-saving automation exists for the supervisory role itself. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Regulatory frameworks (CLIA, CAP accreditation) and professional standards typically require a licensed histotechnologist or pathologist to supervise laboratory activities; legal and certification barriers create substantial friction against full automation. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Histology supervisors typically require certification/licensure and legal accountability for lab quality and compliance (e.g., CLIA), creating strong regulatory and liability barriers to automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | AI tools for lab data monitoring and documentation are emerging but expensive relative to their narrow scope; they do not yet approach the cost-effectiveness needed to substitute for a supervisor's full wages when oversight and accountability are factored in. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | There is no AI substitute performing this supervisory function, so cost comparison favors the human by default since AI cannot deliver the output at all. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 1/5 | No deployed AI product reliably performs laboratory supervision end-to-end. Lab supervision demands physical presence, real-time equipment interaction, and contextual judgment about staff and processes that fall outside current AI system capabilities. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed AI product supervises histology lab staff or operations; existing lab software offers monitoring/data tools but not managerial supervision. |
Embed tissue specimens into paraffin wax blocks, or infiltrate tissue specimens with wax.
5CI 5–5 · exposure 0 · augmentation 25 · importance 4.9/5 · click for rater detail
Embed tissue specimens into paraffin wax blocks, or infiltrate tissue specimens with wax.
5| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 1/5 | Histology labs remain relatively low-digitization, labor-intensive environments with strong institutional inertia and reliance on skilled technicians. Automation adoption in this sector has been slow, with most labs still using manual or semi-automated equipment from prior decades. |
| Sector adoption velocity | claude-sonnet-5 | 1/5 | Histology and pathology lab work remains a physically-oriented, lab-bench sector with low AI adoption for hands-on specimen processing tasks like embedding. |
| Augmentation potential | claude-haiku-4-5-20251001 | 2/5 | Current AI offers minimal assistance for tissue embedding itself; some labs use automated tissue processors for infiltration steps, but this is equipment-based, not AI. AI vision systems might assist in quality inspection post-embedding, but this is tangential to the core embedding task. |
| Augmentation potential | claude-sonnet-5 | 2/5 | AI offers minimal direct assistance for the physical embedding process itself, though some automated embedding machines exist as non-AI robotic tools, and AI could assist with workflow tracking or quality documentation. |
| Task automatability | claude-haiku-4-5-20251001 | 1/5 | This task requires precise physical handling of delicate tissue specimens and equipment operation in a controlled environment. Current AI systems have no capability to perform the fine motor manipulation, temperature control, and real-time sensory feedback needed for tissue embedding and wax infiltration. |
| Task automatability | claude-sonnet-5 | 1/5 | This is a precise physical manipulation task requiring handling delicate tissue, orienting it correctly, and manually controlling wax infiltration/embedding equipment—no AI system can perform this physical process today. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Clinical labs typically require certified personnel to perform or validate specimen processing steps, and there are accreditation standards (CLIA, CAP) governing specimen handling integrity. Liability concerns around specimen damage and regulatory oversight of automated processing create strong adoption friction. |
| Adoption barriers | claude-sonnet-5 | 4/5 | This task typically requires certified histotechnologists/technicians following strict lab protocols and quality standards (e.g., CLIA, CAP) for diagnostic accuracy, creating strong regulatory and training barriers to automation by non-physical AI. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 1/5 | The capital cost of a specialized robotic histology system, combined with integration, maintenance, and oversight, far exceeds the loaded wage of a histotechnologist for this task. Current technology is prohibitively expensive relative to skilled manual labor. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | There is no AI alternative to compare costs against; the task requires human dexterity and physical equipment, making AI substitution currently infeasible and thus not cheaper. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 1/5 | No deployed AI products perform tissue embedding or wax infiltration. This is fundamentally a robotic manipulation task requiring specialized lab equipment integration, which remains in research stages and not production-ready in clinical or research labs. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed AI product performs tissue embedding; this remains a manual laboratory technique performed by trained histotechnologists using embedding stations and molds. |
Cut sections of body tissues for microscopic examination, using microtomes.
5CI 5–5 · exposure 0 · augmentation 25 · importance 4.8/5 · click for rater detail
Cut sections of body tissues for microscopic examination, using microtomes.
5| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 1/5 | Histology remains a largely manual, hands-on field with limited digital transformation; adoption of AI-driven automation in tissue sectioning is extremely rare, and most labs continue reliance on trained technologists. |
| Sector adoption velocity | claude-sonnet-5 | 1/5 | Clinical histology labs are a physically intensive, highly regulated, low-digitization environment where AI adoption for the hands-on sectioning step is essentially nonexistent. |
| Augmentation potential | claude-haiku-4-5-20251001 | 2/5 | AI could assist with image-based quality control (detecting artifacts or optimal section thickness post-hoc) or scheduling, but offers minimal real-time assistance during the cutting process itself, where the histotechnologist's skill and judgment remain central. |
| Augmentation potential | claude-sonnet-5 | 2/5 | AI/automation offers minor assistance via mechanized microtomes or workflow tracking, but the core cutting skill remains manual with little AI-driven productivity enhancement. |
| Task automatability | claude-haiku-4-5-20251001 | 1/5 | Cutting precise tissue sections with a microtome requires fine motor control, real-time haptic feedback, and adaptive response to tissue properties that current AI systems cannot reliably perform end-to-end. No AI system operates microtomes autonomously in production. |
| Task automatability | claude-sonnet-5 | 1/5 | Physically cutting thin tissue sections with a microtome requires fine manual dexterity, tactile feedback, and real-time adjustment that current AI systems cannot perform; this is a physical manipulation task, not a cognitive/data task AI can execute end-to-end. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Regulatory frameworks (CLIA, ISO 15189) require documented quality control and traceability of tissue preparation; labs typically require human oversight and sign-off on section quality, creating organizational and liability friction against full automation. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Tissue sectioning for diagnostic pathology is tightly regulated (CLIA, lab accreditation standards) and typically requires certified histotechnologists, creating strong procedural and liability barriers to non-human performance. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 1/5 | The capital cost of integrating robotic microtome systems, plus ongoing maintenance and quality oversight, would substantially exceed the loaded wage of a trained histotechnologist performing this task. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | There is no viable AI substitute performing this physical task, so cost comparison favors the human technologist entirely; any automation would require expensive specialized robotics, not standard AI inference. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 1/5 | No deployed product demonstrates reliable autonomous microtome operation today. This remains a manual, skilled technical task requiring human dexterity and tactile judgment that has seen no meaningful automation in clinical or research labs. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed AI or robotic product performs microtomy sectioning in production histology labs today; automated sectioning devices exist as mechanical aids but are not AI-driven and still require skilled human operation. |
Related occupations — Healthcare Practitioners & Technical
How to read this
A high substitution score does not mean this job disappears — it means a large share of its current tasks face replacement pressure, so the mix of tasks is likely to change. High augmentation alongside substitution typically means the occupation reorganizes around the protected tasks. Wide confidence intervals mean the rater panel disagreed: treat those scores as open questions, not verdicts.
What would change this score
New model capabilities (automatability, feasibility), falling inference costs (cost ratio), regulation and licensing shifts (barriers), and measured sector adoption (velocity) all re-enter at every index release. Each release is recomputed, versioned and kept queryable — scores are claims with a date on them, not permanent labels.